HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report)’s share price traded down 3.7% during trading on Monday . The stock traded as low as $3.15 and last traded at $3.15. 5,100 shares were traded during mid-day trading, an increase of 419% from the average session volume of 983 shares. The stock had previously closed at $3.27.
HLS Therapeutics Trading Down 3.7 %
The business has a fifty day moving average price of $2.83 and a two-hundred day moving average price of $2.65.
HLS Therapeutics Company Profile
HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.
Read More
- Five stocks we like better than HLS Therapeutics
- High Flyers: 3 Natural Gas Stocks for March 2022
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Top Biotech Stocks: Exploring Innovation Opportunities
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
